MYRANDA GUILLEN: Open Payments
NPI 1902500416 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$102 in 5 payments from 3 companies in 2025. Trend: 2023 $420 · 2024 $243 · 2025 $102
Food & beverage: $102
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 3 | $66 |
| Astellas Pharma US Inc | 1 | $21 |
| Octapharma USA, Inc. | 1 | $15 |
Products named: Veozah, FIBRYGA.
Industry payments across NV — which companies pay providers there.
